| enoxaparin versus UFH | |||
| ATOLL, 2010 | IV enoxaparin versus UFH | patients undergoing PCI for acute STEMI | open Follow-up duration: 30 days Austria, France, Germany, and US |
| Brieger, | enoxaparin versus unfractionated heparin | patients undergoing percutaneous coronary intervention for ST-segment elevation myocardial infarction (STEMI) | |
in first
in second